S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

Stericycle (NASDAQ:SRCL) Rating Lowered to D+ at TheStreet

Last updated on Saturday, May 14, 2022 | 2022 MarketBeat

Stericycle (NASDAQ:SRCL - Get Rating) was downgraded by investment analysts at TheStreet from a "c" rating to a "d+" rating in a report issued on Thursday, TheStreetRatingsTable reports.

Several other research analysts have also weighed in on SRCL. Zacks Investment Research upgraded Stericycle from a "sell" rating to a "hold" rating and set a $58.00 price objective for the company in a research report on Wednesday, April 27th. Barrington Research restated a "market perform" rating on shares of Stericycle in a research report on Tuesday, April 19th. StockNews.com lowered Stericycle from a "buy" rating to a "hold" rating in a research report on Thursday, April 21st. Robert W. Baird lowered their price target on Stericycle from $72.00 to $63.00 in a research report on Friday, April 29th. Finally, Berenberg Bank lowered Stericycle from a "buy" rating to a "hold" rating and lowered their price target for the stock from $95.00 to $46.00 in a research report on Thursday. They noted that the move was a valuation call. Five research analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat.com, Stericycle currently has a consensus rating of "Hold" and an average target price of $58.50.

Shares of Stericycle stock opened at $46.05 on Thursday. The firm has a market capitalization of $4.24 billion, a price-to-earnings ratio of -62.23, a PEG ratio of 2.78 and a beta of 1.31. Stericycle has a fifty-two week low of $44.04 and a fifty-two week high of $79.97. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.92 and a current ratio of 0.92. The stock has a 50 day moving average of $54.58 and a 200 day moving average of $57.73.

Stericycle (NASDAQ:SRCL - Get Rating) last issued its quarterly earnings data on Thursday, April 28th. The business services provider reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.13). The business had revenue of $664.20 million during the quarter, compared to analysts' expectations of $669.61 million. Stericycle had a positive return on equity of 6.84% and a negative net margin of 2.58%. The company's revenue was down .6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.71 earnings per share. Analysts forecast that Stericycle will post 2.09 EPS for the current year.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Ancora Advisors LLC acquired a new stake in shares of Stericycle in the first quarter valued at $34,000. Quent Capital LLC acquired a new stake in shares of Stericycle in the fourth quarter valued at $33,000. First Horizon Advisors Inc. raised its stake in shares of Stericycle by 1,369.2% in the third quarter. First Horizon Advisors Inc. now owns 573 shares of the business services provider's stock valued at $43,000 after acquiring an additional 534 shares in the last quarter. Covestor Ltd acquired a new stake in shares of Stericycle in the fourth quarter valued at $43,000. Finally, CastleArk Alternatives LLC acquired a new stake in shares of Stericycle in the third quarter valued at $52,000. Institutional investors and hedge funds own 99.89% of the company's stock.

Stericycle Company Profile (Get Rating)

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including sharps disposable and management solutions; pharmaceutical waste services; hazardous waste disposal; maritime waste services, such as seaport and airport waste; and compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in Stericycle right now?

Before you consider Stericycle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stericycle wasn't on the list.

While Stericycle currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here



Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.